Expression of PVR in Cervical Cancer and Its Impact on Tumor Immune Microenvironment Based on TCGA Data

Xiao Bing,Sun Haiying,Meng Silu,Yuan Yuqi,Li Xiangqin,Fan Xinran,Ning Ruoqi,Li Shuang

DOI: https://doi.org/10.3969/j.issn.1674-0904.2023.03.006

2023-01-01

Abstract:Objective : To investigate the expression level of PVR and its receptor TIGIT gene in cervical cancer and its relationship with clinicopathological features and prognosis, and preliminarily study the role PVR and TIGIT play in cervical carcinogenesis and tumor immune microenvironment. Methods:Difference in the expressions of PVR and TIGIT between tumor and normal tissues were compared based on The Cancer Genome Atlas（TCGA） RNA-sequencing expression matrix, and the relationship of their expressions with clinicopathological characteristics and prognosis of cervical cancer was analyzed. Correlation analysis identified the genes relevant to PVR or TIGIT expression, and Gene Set Enrichment Analysis was applied to annotate their functions. The immune cell infiltration of cervical cancer was calculated, and their association with PVR or TIGIT expression was analyzed by using TCGA. Immunohistochemistry was used to validate the expression level of CD155 encoded by PVR and that of TIGIT, and their correlations to CD8+ T cells and PD1 expressions. Results : PVR and TIGIT were up-regulated in multiple cancers than in the normal group. The PVR expression level was an independent predictor of the overall survial of cervical cancer patients,and high PVR expression level was significantly correlated to worse overall survival. PVR was associated with several hallmark pathways that promote carcinogenesis, such as MYC target, angiogenesis, TGF-β signaling, TNF-α/NF-κB signaling, PI3K/AKT/mTOR signaling and Hedgehog signaling, etc. PVR expression was negatively correlated to immune scores as well as the infiltration levels of CD8 T cells, follicular helper T cells, Treg cells, resting mast cells and resting dendritic cells. TIGIT was co-expressed with signaling pathways related to immune-related pathways, and was positively correlated to immune cell and stromal cell infiltration. TIGIT was co-expressed with PD1 in immunohistochemistry. Conclusion : PVR may mediate multiple mechanisms of cervical carcinogenesis, and cause suppression and evasion in tumor microenvironment. Increased TIGIT expression may be one of the mechanisms for cervical cancer to escape from the immune system. Inhibitors targeting CD155/TIGIT might be a future treatment of cervical cancer.